Atlantic Bridge University Fund logo

Atlantic Bridge University Fund

Europe, Dublin, Ireland, Dublin

Description

The Atlantic Bridge University Fund is a specialized venture capital initiative launched by Atlantic Bridge, a global growth equity firm, in partnership with the European Investment Fund (EIF) and eight leading Irish universities. Established in 2018, the fund's primary objective is to commercialize cutting-edge research and intellectual property emerging from these academic institutions, transforming them into high-growth, world-class technology companies. It specifically targets deep tech ventures, including areas like AI, IoT, advanced materials, and life sciences, that originate from university research labs.

This dedicated fund plays a crucial role in bridging the gap between academic innovation and market readiness within the Irish ecosystem. With a total capital commitment of €60 million (approximately $64.8 million USD), the fund aims to provide essential early-stage capital to promising spin-out companies. Its investment strategy focuses on seed and Series A rounds, supporting entrepreneurs with the ambition to scale their ventures globally. The fund's unique structure, involving direct collaboration with eight universities, provides it with privileged access to a pipeline of groundbreaking technologies and scientific talent.

The Atlantic Bridge University Fund typically makes initial investments ranging from approximately $500,000 to $2,500,000, depending on the stage of development and capital requirements of the spin-out. These initial cheques are often followed by subsequent investments as companies achieve milestones and progress through later funding rounds. The fund seeks to back companies that demonstrate strong intellectual property, a clear path to market, and a scalable business model, aligning with Atlantic Bridge's broader mandate of investing in companies with the potential for significant global impact. Its focus on deep tech and university-led innovation positions it as a key player in fostering Ireland's knowledge economy.

Investor Profile

Atlantic Bridge University Fund has backed more than 31 startups, with 1 new investments in the last 12 months alone. The firm has led 19 rounds, about 61% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Ireland, United States.
  • Strong thematic focus on Medical Device, Health Care, Big Data.
  • Typical check size: $500K – $2.5M.

Stage Focus

  • Seed (65%)
  • Series A (26%)
  • Series Unknown (6%)
  • Series B (3%)

Country Focus

  • Ireland (97%)
  • United States (3%)

Industry Focus

  • Medical Device
  • Health Care
  • Big Data
  • Natural Language Processing
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Software
  • E-commerce
  • Events
  • Ticketing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Atlantic Bridge University Fund frequently co-invest with?

Irrus Investments
Europe, Limerick, Ireland, Limerick
Co-Investments: 5
Salica
Europe, England, United Kingdom, London
Co-Investments: 2
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 7
Elkstone Capital Partners
Europe, Dublin, Ireland, Dublin
Co-Investments: 5
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 21
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
HBAN
Europe, Dublin, Ireland, Dublin
Co-Investments: 3
Mayo Clinic Ventures
North America, Minnesota, United States, Rochester
Co-Investments: 2
XC
Europe, Galway, Ireland, Galway
Co-Investments: 4
A
Europe, Galway, Ireland, Galway
Co-Investments: 4

Which angels does Atlantic Bridge University Fund often collaborate with?

DB
North America, California, United States
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
JH
Europe, Ireland
Shared Deals: 1

What are some of recent deals done by Atlantic Bridge University Fund?

CroíValve

Dublin, Dublin, Ireland

CroíValve is a developed safe, effective, easy to use, percutaneous solution company.

Medical Device
Series BAug 7, 2024
Amount Raised: $16,000,000
PlasmaBound

Dublin, Dublin, Ireland

PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA).

Building Material
Series UnknownMay 1, 2022
Amount Raised: $2,475,780
CroíValve

Dublin, Dublin, Ireland

CroíValve is a developed safe, effective, easy to use, percutaneous solution company.

Medical Device
Series AFeb 4, 2022
Amount Raised: $9,159,323
ProVerum Medical

Dublin, Dublin, Ireland

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

Health CareMedical Device
Series AJan 11, 2022
Amount Raised: $34,098,000
Tympany Medical

Galway, Galway, Ireland

Tympany Medical is an innovative MedTech Start Up based in Galway, Ireland.

Health CareMedical Device
SeedNov 22, 2021
Amount Raised: $3,934,525
LUMA Vision

Harold's Cross, Dublin, Ireland

LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.

Health CareHealth DiagnosticsMedical Device
Series AOct 14, 2021
Amount Raised: $8,000,000
TerminusDB

Dublin, Dublin, Ireland

TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL.

Big DataDatabaseInformation ServicesInformation Technology
SeedMar 15, 2021
Amount Raised: $4,293,366
Parvalis Therapeutics

Dublin, Dublin, Ireland

Parvalis Therapeutics develops a novel autoimmune therapies for inflammatory diseases and cancer.

BiopharmaHealth CareTherapeutics
SeedJan 1, 2021
PlasmaBound

Dublin, Dublin, Ireland

PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA).

Building Material
SeedJun 24, 2020
Amount Raised: $1,237,494
LUMA Vision

Harold's Cross, Dublin, Ireland

LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.

Health CareHealth DiagnosticsMedical Device
Series AJun 23, 2020
Amount Raised: $12,443,918